On the other hand, gain-of-function p53 oncogenic mutations can result in accelerated tumor metastasis, altered transcriptional activation of target genes, inhibition of apoptosis, and enhanced resistance to chemotherapy [37]. The gene discussed is TP53; the disease is neoplasm.